Pretreatment <sup>18</sup>F-FDG uptake heterogeneity may predict treatment outcome of combined Trastuzumab and Pertuzumab therapy in patients with metastatic HER2 positive breast cancer.
Journal Information
Full Title: Cancer Imaging
Abbreviation: Cancer Imaging
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Diagnostic Imaging
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Declarations Ethics approval and consent to participateSee the method section in the text for details. Consent for publicationNot applicable. Competing interestsThe authors declare that they have no competing interests. Competing interests The authors declare that they have no competing interests."
"Funding This work was supported by grants from the Shanghai Committee of Science and Technology Fund (22DZ2204500), Shanghai Municipal Health Commission (202040269), National Natural Science Foundation of China (81901778), Shanghai Sailing Program (20YF1408500)."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025